Compare Novartis AG (NVS) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Transocean Ltd — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Transocean Ltd trades at $5.23 (market cap $5.56B). The key difference: Novartis AG is far larger — about 52.2× Transocean Ltd's market cap, and Novartis AG pays a 3.17% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals.
| NVS | RIG | |
|---|---|---|
Market Cap | $290.25B | $5.56B |
Sector | Health | Technology |
52-Week High | $168.62 | $7.58 |
52-Week Low | $113.50 | $2.64 |
Enterprise Value | $330.27B | $10.50B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
